CF Phase 2 Trials Testing ELX-02 Nears Complete Enrollment, Eloxx Says
Two Phase 2 clinical trials testing the treatment ELX-02 in people with cystic fibrosis are nearing completion, Eloxx Pharmaceuticals announced. Click here to read more.
What do you think about this news?
Sorry, there were no replies found.
Log in to reply.